FDA Science Board, Industry Seek Combination Product Review Reform
This article was originally published in The Gray Sheet
Executive Summary
Center for Devices and Radiological Health Director David Feigal and Center for Biologics Evaluation and Research Director Kathryn Zoon have been meeting with industry representatives to discuss the agency's mechanism for tracking combination products reviews
You may also be interested in...
Kramer Continues Combo Product Stewardship, Fosters Intercenter Consults
FDA Office of Combination Products Director Mark Kramer will be assisted by Suzanne O'Shea, who is leaving the Office of the Ombudsman to serve as product assignment officer
Kramer Continues Combo Product Stewardship, Fosters Intercenter Consults
FDA Office of Combination Products Director Mark Kramer will be assisted by Suzanne O'Shea, who is leaving the Office of the Ombudsman to serve as product assignment officer
FDA Reform Bill Introduced Dec. 20 By Reps. Greenwood, Eshoo
Device-related FDA reform legislation will be pending in the House when the 107th Congress returns for its second legislative session in January